Bernstein Reiterates Buy on UNH with $512 Price Target
Bernstein's Lance Wilkes has maintained his 'buy' rating for UnitedHealth (UNH.US), and stuck to his target price of $512.
The analyst, who boasts a success rate of 61.3% and an average return of 12.1% over the past year according to TipRanks data, remains optimistic about the company's prospects.